GHS Classification Guidance for the Japanese Government
GHS Classification Guidance for the Japanese Government GHS Classification Guidance for the Japanese Government
The classification is based on any of the following. a) Positive result(s) from in vivo heritable germ cell mutagenicity tests in mammals; or b) Positive result(s) from in vivo somatic germ cell mutagenicity tests in mammals, in combination with some evidence that the substance has potential to cause mutations to germ cells. This supporting evidence may, for example, be derived from mutagenicity/genotoxic tests in germ cells in vivo, or by demonstrating the ability of the substance or its metabolite(s) to interact with the genetic material of germ cells; or c) Positive results from tests showing mutagenic effects in the germ cells of humans, without demonstration of transmission to progeny; for example, an increase in the frequency of aneuploidy in sperm cells of exposed human subjects. Category 2:Chemicals which cause concern for humans owing to the possibility that they may induce heritable mutations in the germ cells of humans. The classification is based on any of the following. a) Somatic cell mutagenicity tests in vivo, in mammals; or b) Other in vivo somatic cell genotoxicity tests which are supported by positive results from in vitro mutagenicity assays. Note: Chemicals which are positive in in vitro mammalian mutagenicity assays, and which also show chemical structure-activity relationship to known Germ Cell mutagens, should be considered for classification as Category 2 mutagens. B) Classification criteria in GHS (Reference information) In classification criteria of JIS Classification and those of GHS, the same categories are adopted. (3)Items on information sources and data *Regarding procedure of classification, refer to “3-1-1Sources of information available for classification” A)Data availability 1) In the UN GHS second revised edition, “mutagenicity tests” and “genotoxicity tests” have different meanings. The mutagenicity tests are tests indexed with gene mutation, structural and numerical abnormality of chromosome, and the genotoxicity tests are tests indexed with other elements, for example, DNA damage and DNA repairing. There exist extremely many kinds of mutagenicity tests and genotoxicity tests, and GHS shows examples of test methods that provide criteria for classification as heritable mutagens (Note) in humans. In table 3-8, in addition to GHS examples, several test methods are included to provide data that serve as the basis for classification. (Note) The purport of GHS Categories is to take account of heritable mutagenicity effects in 142
humans. In this guidance, to facilitate understanding, the term “heritable mutagenicity” is used in addition to “germ cell mutagenicity.” The “germ cell mutagenicity” means effects to induce mutagenicity/genotoxicity in germ cells, and “heritable mutagenicity” means effects to induce gene mutation chromosamal abnormality in future generation of the mutagenicity recognized in germ cells. In the UN GHS second revised edition, the term “heritable mutagenicity” is not used, but the corresponding phrase “to induce heritable mutations in germ cells of humans” is used. 2) The UN GHS second revised edition 3.5.5.1 “Decision logic 3.5.1 for substances” starts with the question, “Does the substance have data on mutagenicity ?”. The phrase “data on mutagenicity” basically means data obtained from in vivo mutagenicity/genotoxicity tests that are generally used and normally means a set of data including those obtained from in vitro tests. Expert's support is required for making a decision on mutagenicity based on multiple conflicting test results. 3) For many chemicals, results from many mutagenicity tests (or genotoxicity tests) are reported including in vitro tests, but results from in vivo tests using mammalian germ cells are rare. Expert's evaluation and decision are required for passing judgment on mutagenicity to human germ cells based on a large amount of In vitro and in vivo test reports. 4) Although human data are precious, usage of epidemiological data is extremely limited since , in many cases, data obtained from human monitoring exposed with some chemicals (for example, chromosome analysis on human peripheral lymphocytes) show unclear effects by the chemicals, and since the number of subjects is not sufficient to give a generalized conclusion. Epidemiological data may provide conflicting results, but they may be easily used when the validity of the finding (negative or positive) is recognized by assessment documents in List 1. 5) Chemicals having dataset from in vivo and in vitro tests are less in number than chemicals having in vitro test data only. In general, it is difficult to determine the existence of heritable mutagenicity based on results of in vitro tests only. 6) Results from rodent spermshape abnormality test shall not be used in this classification in principle since they may be affected by effects to other than genetic materials 143
- Page 96 and 97: 1-1) Organization National Institut
- Page 98 and 99: URL http://www.ecetoc.org/publicati
- Page 100 and 101: List 2: Useful information sources
- Page 102 and 103: http://www.cdc.gov/niosh/npg/npgdrt
- Page 104 and 105: 3-1-3 Management of information in
- Page 106 and 107: Relation between concentration(ppm)
- Page 108 and 109: follows: Category 1 (100 ppmV), Cat
- Page 110 and 111: (ii) the appropriate conversion val
- Page 112 and 113: UNRTDG Class 6.1 is not sub-categor
- Page 114 and 115: possible” unless the obvious conc
- Page 116 and 117: whereas the reference value is set
- Page 118 and 119: 3-2-2 Skin Corrosion/Irritation (1)
- Page 120 and 121: Table 3.2.2 Skin irritation categor
- Page 122 and 123: possible, and to classify the subst
- Page 124 and 125: and scaling persist to the end of 1
- Page 126 and 127: 【GHS 2 nd revised edition】 Figu
- Page 128 and 129: [Note for the above figure] (a) Cla
- Page 130 and 131: B) Classification criteria in GHS (
- Page 132 and 133: (4)Guidance for classification and
- Page 134 and 135: G) Strategy of testing and evaluati
- Page 136 and 137: 2c Structure activity Skin corrosiv
- Page 138 and 139: done in parallel. This stage should
- Page 140 and 141: criteria given below:” a) If ther
- Page 142 and 143: [Decision Criteria 1]: In the cases
- Page 144 and 145: substance shall be classified in Ca
- Page 148 and 149: 7) Data from various kinds of tests
- Page 150 and 151: Table 3-8 Test data as the basis of
- Page 152 and 153: Category 1B. Mutagens classified a
- Page 154 and 155: c)Exceptionally, strong positive re
- Page 156 and 157: 3-2-6 Carcinogenicity (1)Definition
- Page 158 and 159: The principles of GHS classificatio
- Page 160 and 161: B) Substance for which GHS classifi
- Page 162 and 163: metabolic system, a cautious invest
- Page 164 and 165: hazard warning for pregnant women a
- Page 166 and 167: OECD414 Prenatal development toxici
- Page 168 and 169: D) Decision logic and classificatio
- Page 170 and 171: e considered to be sufficient. (Sub
- Page 172 and 173: No. Test guideline Limit dose 414 P
- Page 174 and 175: 3-2-8 Specific Target Organ Toxicit
- Page 176 and 177: specifically for these effects as d
- Page 178 and 179: existing MSDSs. A literature search
- Page 180 and 181: * Unless a description that definit
- Page 182 and 183: g) When the affected organ can be i
- Page 184 and 185: 3-2-9 Specific Target Organ Toxicit
- Page 186 and 187: Table 3-16: Guidance value ranges f
- Page 188 and 189: (c) Any consistent and significant
- Page 190 and 191: has received some degree of approva
- Page 192 and 193: As for the classification of specif
- Page 194 and 195: formed in the mouth, which then may
The classification is based on any of <strong>the</strong> following.<br />
a) Positive result(s) from in vivo heritable germ cell mutagenicity tests in mammals; or<br />
b) Positive result(s) from in vivo somatic germ cell mutagenicity tests in mammals, in<br />
combination with some evidence that <strong>the</strong> substance has potential to cause mutations to<br />
germ cells. This supporting evidence may, <strong>for</strong> example, be derived from<br />
mutagenicity/genotoxic tests in germ cells in vivo, or by demonstrating <strong>the</strong> ability of <strong>the</strong><br />
substance or its metabolite(s) to interact with <strong>the</strong> genetic material of germ cells; or<br />
c) Positive results from tests showing mutagenic effects in <strong>the</strong> germ cells of humans, without<br />
demonstration of transmission to progeny; <strong>for</strong> example, an increase in <strong>the</strong> frequency of<br />
aneuploidy in sperm cells of exposed human subjects.<br />
Category 2:Chemicals which cause concern <strong>for</strong> humans owing to <strong>the</strong> possibility that <strong>the</strong>y may<br />
induce heritable mutations in <strong>the</strong> germ cells of humans.<br />
The classification is based on any of <strong>the</strong> following.<br />
a) Somatic cell mutagenicity tests in vivo, in mammals; or<br />
b) O<strong>the</strong>r in vivo somatic cell genotoxicity tests which are supported by positive results from in<br />
vitro mutagenicity assays.<br />
Note: Chemicals which are positive in in vitro mammalian mutagenicity assays, and which also<br />
show chemical structure-activity relationship to known Germ Cell mutagens, should be<br />
considered <strong>for</strong> classification as Category 2 mutagens.<br />
B) <strong>Classification</strong> criteria in <strong>GHS</strong> (Reference in<strong>for</strong>mation)<br />
In classification criteria of JIS <strong>Classification</strong> and those of <strong>GHS</strong>, <strong>the</strong> same categories are<br />
adopted.<br />
(3)Items on in<strong>for</strong>mation sources and data<br />
*Regarding procedure of classification, refer to “3-1-1Sources of in<strong>for</strong>mation<br />
available <strong>for</strong> classification”<br />
A)Data availability<br />
1) In <strong>the</strong> UN <strong>GHS</strong> second revised edition, “mutagenicity tests” and “genotoxicity tests” have<br />
different meanings. The mutagenicity tests are tests indexed with gene mutation, structural<br />
and numerical abnormality of chromosome, and <strong>the</strong> genotoxicity tests are tests indexed<br />
with o<strong>the</strong>r elements, <strong>for</strong> example, DNA damage and DNA repairing. There exist extremely<br />
many kinds of mutagenicity tests and genotoxicity tests, and <strong>GHS</strong> shows examples of test<br />
methods that provide criteria <strong>for</strong> classification as heritable mutagens (Note) in humans. In<br />
table 3-8, in addition to <strong>GHS</strong> examples, several test methods are included to provide data<br />
that serve as <strong>the</strong> basis <strong>for</strong> classification.<br />
(Note) The purport of <strong>GHS</strong> Categories is to take account of heritable mutagenicity effects in<br />
142